News

Deal Announcements

EndoStim Secures New Venture Capital Equity

Tuesday, May 12, 2015 5:45:00 AM PDT | VentureDeal
   St. Louis, Missouri  --  Medical device company EndoStim has landed $2.5 million in venture capital investment, according to an SEC regulatory filing.

EndoStim is developing "novel micro stimulator technology to treat a number of widely prevalent reflux-related disorders."

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

EndoStim is still seeking $2.5 million in additional financing, according to the filing.

The minimum investment size per investor is $2.5 million.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1